3

OWNERSHIP DOCUMENT

Company: Milestone Pharmaceuticals Inc.
Filed: May 8, 2019
Period of Report: May 8, 2019
Accession Number: 0000950142-19-001031

View Document ↗ View on SEC.gov ↗